{
    "accession": "ENCBS900CSN",
    "age": "30",
    "age_units": "year",
    "applied_modifications": [],
    "biosample_term_id": "NTR:0000502",
    "biosample_term_name": "activated naive CD8-positive, alpha-beta T cell",
    "biosample_type": "primary cell",
    "characterizations": [],
    "dbxrefs": [
        "GEO:SAMN22819109"
    ],
    "description": "naive CD8+ cell, activated Day 7",
    "documents": [],
    "donor": "ENCDO166AGR",
    "lab": "Barbara Wold, Caltech",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "male",
    "source": "AllCells",
    "summary": "Homo sapiens male adult (30 years) activated naive CD8-positive, alpha-beta T primary cell treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 5,
            "duration_units": "day",
            "treatment_term_id": "UniProtKB:P60568",
            "treatment_term_name": "Interleukin-2",
            "treatment_type": "protein"
        },
        {
            "dbxrefs": [],
            "duration": 7,
            "duration_units": "day",
            "treatment_term_name": "anti-CD3 and anti-CD28 coated beads",
            "treatment_type": "antibody"
        }
    ]
}